Showing posts with label HIV. Show all posts
Showing posts with label HIV. Show all posts

Monday, 27 April 2020

Pretty lady Marks 20 years of leaving with HIV since the age of 8

The 27-year-old Kenyan woman recently shared a video of herself celebrating 20 years of living with HIV as well as her childhood photos to tell her story to the world.

According to her, after diagnosing her of the disease, doctors said she wouldn’t grow past her 12th birthday, saying she had only four more years to live when she was as young as eight.

However, as fate would have it, she has surpassed the deadline several folds and now marks 20 years of living with the dreadful virus.

“2020 marks exactly 20 years since I was diagnosed with HIV. I was 8 years old when my parents were told I was HIV positive. Pensive face doctors gave me up to my 12th birthday. This August I'm looking forward to my 28th birthday. God is not done with me yet," she wrote

Her story triggered a lot of reactions on social media with many users applauding her for the courage and the sense of positivity that made her overcome stigmatization and always living a life full of smile and joy.

Tuesday, 7 April 2020

HIV drug which successfully treats coronavirus is moving to phase 2 trials

An experimental HIV drug that has been used to successfully treat COVID-19 patients is in its second phase of testing with the Food and Drug Administration and could potentially be approved for use in four weeks, its manufacturer says.

Leronlimab, made by the biotech company CytoDyn, was used to treat a handful of severely ill patients in New York City hospitals; a couple were able to be removed from their ventilators.

"I think the FDA will be willing to work with us," CytoDyn CEO Nader Pourhassan told The Post.

"I am hoping it will be expedited … I don’t see how the FDA couldn’t approve it."

Pourhassan added: "With a study in China indicating the mortality rate among COVID-19 patients requiring mechanical ventilators at more than 85 percent, the world desperately needs a therapy that can help this patient population.

Initial studies suggest leronlimab can reduce the overactive immune response, known as a cytokine storm, that can be triggered by the coronavirus infection. Cytokine storms can result in pneumonia and even death.

"[I] cried for about five minutes. It was very, very emotional," Pourhassan told Seattle’s KIRO 7 News after first learning of the results. "We’re hoping we can save millions of lives."

Source: Seattle’s KIRO 7 News